225 related articles for article (PubMed ID: 3475819)
1. Alloimmunization following platelet transfusions in patients with acute nonlymphocytic leukemia.
Nozaki H; Shimizu M; Komatsuda M; Watanabe K; Nagao T; Arimori S
Tokai J Exp Clin Med; 1986 Aug; 11(3):201-4. PubMed ID: 3475819
[TBL] [Abstract][Full Text] [Related]
2. [Platelet alloimmunization in patients with oncologic blood disorders treated with multiple transfusions: prospective study in adults and children].
Pereira J; Bronfman L; Bertín P; Marzouka E; Hidalgo P; Amaya S; Mezzano D
Rev Med Chil; 1997 Nov; 125(11):1305-12. PubMed ID: 9609051
[TBL] [Abstract][Full Text] [Related]
3. Bleeding risk and platelet transfusion refractoriness in patients with acute myelogenous leukemia who undergo autologous stem cell transplantation.
Toor AA; Choo SY; Little JA
Bone Marrow Transplant; 2000 Aug; 26(3):315-20. PubMed ID: 10967572
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up patients with leukemia receiving platelet transfusions: identification of a large group of patients who do not become alloimmunized.
Dutcher JP; Schiffer CA; Aisner J; Wiernik PH
Blood; 1981 Nov; 58(5):1007-11. PubMed ID: 6794674
[TBL] [Abstract][Full Text] [Related]
5. Platelet alloimmunization in multitransfused patients with haemato-oncological disorders.
Bajpai M; Kaura B; Marwaha N; Kumari S; Sharma RR; Agnihotri SK
Natl Med J India; 2005; 18(3):134-6. PubMed ID: 16130614
[TBL] [Abstract][Full Text] [Related]
6. Platelet antibody screening in patients with leukemia and aplastic anemia.
Chow MP; Yung CH; Tzeng JL; Hu HY; Lin WM
Zhonghua Yi Xue Za Zhi (Taipei); 1991 Apr; 47(4):237-41. PubMed ID: 1646672
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of 4 crossmatching methods for predicting the success of platelet transfusion].
Santoso S; Kiefel V; Kühn J; Mueller-Eckhardt G; Mueller-Eckhardt C
Beitr Infusionsther; 1990; 26():153-6. PubMed ID: 1703818
[TBL] [Abstract][Full Text] [Related]
8. [Measurement of anti-HLA antibody by lymphocytotoxicity test in patients with hematopoietic diseases].
Kambayashi H; Ohto H; Kariyone S; Tanaka T
Rinsho Ketsueki; 1989 Jun; 30(6):815-22. PubMed ID: 2795892
[TBL] [Abstract][Full Text] [Related]
9. Supportive care for children with cancer. Guidelines of the Childrens Cancer Study Group. The use of platelet transfusions.
Feusner J
Am J Pediatr Hematol Oncol; 1984; 6(3):255-60. PubMed ID: 6393789
[TBL] [Abstract][Full Text] [Related]
10. Current status of leukocyte and platelet administration in cancer therapy.
Walker EM; Cannon A; Mitchum EN
Ann Clin Lab Sci; 1983; 13(6):453-73. PubMed ID: 6197928
[TBL] [Abstract][Full Text] [Related]
11. [Ineffective platelet transfusion in patients with hematology malignancy].
Chen S; Xiao L; Zou X
Zhonghua Yi Xue Za Zhi; 1998 Nov; 78(11):824-6. PubMed ID: 11038776
[TBL] [Abstract][Full Text] [Related]
12. Refractoriness to random donor platelet transfusions in patients with aplastic anaemia: a multivariate analysis of data from 264 cases.
Klingemann HG; Self S; Banaji M; Deeg HJ; Doney K; Slichter SJ; Thomas ED; Storb R
Br J Haematol; 1987 May; 66(1):115-21. PubMed ID: 3593647
[TBL] [Abstract][Full Text] [Related]
13. Persistence of lymphocytotoxic antibodies in patients in the trial to reduce alloimmunization to platelets: implications for using modified blood products.
Slichter SJ; Bolgiano D; Kao KJ; Kickler TS; McFarland J; McCullough J; Woodson R
Transfus Med Rev; 2011 Apr; 25(2):102-10. PubMed ID: 21345638
[TBL] [Abstract][Full Text] [Related]
14. The platelet-refractory bone marrow transplant patient: prophylaxis and treatment of bleeding.
Benson K; Fields K; Hiemenz J; Zorsky P; Ballester O; Perkins J; Elfenbein G
Semin Oncol; 1993 Oct; 20(5 Suppl 6):102-9. PubMed ID: 8211211
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of anti-platelet antibodies using flow cytometry].
Tsubaki K
Rinsho Byori; 1993 Sep; 41(9):998-1006. PubMed ID: 8254978
[TBL] [Abstract][Full Text] [Related]
16. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions.
Trial to Reduce Alloimmunization to Platelets Study Group
N Engl J Med; 1997 Dec; 337(26):1861-9. PubMed ID: 9417523
[TBL] [Abstract][Full Text] [Related]
17. Alloimmunization following platelet transfusion: the absence of a dose-response relationship.
Dutcher JP; Schiffer CA; Aisner J; Wiernik PH
Blood; 1981 Mar; 57(3):395-8. PubMed ID: 7459428
[TBL] [Abstract][Full Text] [Related]
18. Alloimmunization following prophylactic granulocyte transfusion.
Schiffer CA; Aisner J; Daly PA; Schimpff SC; Wiernik PH
Blood; 1979 Oct; 54(4):766-74. PubMed ID: 476300
[TBL] [Abstract][Full Text] [Related]
19. [Thrombocyte transfusion: increase in platelets in relation to clinical and immunologic prerequisites].
Panzer S; Maier F; Höcker P; Mayr WR; Hinterberger W
Infusionsther Klin Ernahr; 1987 Apr; 14 Suppl 2():10-4. PubMed ID: 3298059
[TBL] [Abstract][Full Text] [Related]
20. Cryopreserved autologous platelet transfusions in alloimmunized patients with acute leukemia.
Wiesneth M; Koerner K; Funke I; Seifried E; Cardoso M; Heimpel H; Kubanek B
Beitr Infusionsther; 1992; 30():297-300. PubMed ID: 1284720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
